| Title : A Randomized, Placebo-controlled Study to Evaluate the Efficacy and Safety of Adding Omarigliptin to Insulin Therapy in Japanese Patients with Type 2 Diabetes and Inadequate Glycemic Control - Kadowaki_2021_Diabetes.Obes.Metab__ |
| Author(s) : Kadowaki T , Seino Y , Kaku K , Okamoto T , Kameya M , Sato A , Hirano T , Oshima N , Gantz I , O'Neill EA , Engel SS |
| Ref : Diabetes Obes Metab , : , 2021 |
| Abstract : |
| PubMedSearch : Kadowaki_2021_Diabetes.Obes.Metab__ |
| PubMedID: 33512755 |
| Title : A randomized, placebo-controlled clinical trial evaluating the safety and efficacy of the once-weekly DPP-4 inhibitor omarigliptin in patients with type 2 diabetes mellitus inadequately controlled by glimepiride and metformin - Lee_2017_BMC.Endocr.Disord_17_70 |
| Author(s) : Lee SH , Gantz I , Round E , Latham M , O'Neill EA , Ceesay P , Suryawanshi S , Kaufman KD , Engel SS , Lai E |
| Ref : BMC Endocr Disord , 17 :70 , 2017 |
| Abstract : |
| PubMedSearch : Lee_2017_BMC.Endocr.Disord_17_70 |
| PubMedID: 29110647 |
| Title : Safety and tolerability of sitagliptin in clinical studies: a pooled analysis of data from 10,246 patients with type 2 diabetes - Williams-Herman_2010_BMC.Endocr.Disord_10_7 |
| Author(s) : Williams-Herman D , Engel SS , Round E , Johnson J , Golm GT , Guo H , Musser BJ , Davies MJ , Kaufman KD , Goldstein BJ |
| Ref : BMC Endocr Disord , 10 :7 , 2010 |
| Abstract : |
| PubMedSearch : Williams-Herman_2010_BMC.Endocr.Disord_10_7 |
| PubMedID: 20412573 |
| Title : Sitagliptin: review of preclinical and clinical data regarding incidence of pancreatitis - Engel_2010_Int.J.Clin.Pract_64_984 |
| Author(s) : Engel SS , Williams-Herman DE , Golm GT , Clay RJ , Machotka SV , Kaufman KD , Goldstein BJ |
| Ref : Int J Clin Pract , 64 :984 , 2010 |
| Abstract : |
| PubMedSearch : Engel_2010_Int.J.Clin.Pract_64_984 |
| PubMedID: 20412332 |